Tricyclic quinoline and quinoxaline derivatives

The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatme...

Full description

Saved in:
Bibliographic Details
Main Authors Lakics, Viktor, Koolman, Hannes, Hoft, Carolin, Xu, Ruxu, Zhao, Xiaona, Haupt, Andreas, Drescher, Karla, Bakker, Margaretha Henrica Maria, Mack, Helmut, Braje, Wilfried, Relo, Ana Lucia
Format Patent
LanguageEnglish
Published 06.11.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor.
Bibliography:Application Number: US201314026354